NSE filing, NSE: ORCHPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Orchid Pharma Ltd: key numbers
- Share price
- ₹836.45
- Market cap
- ₹5,009 Cr
- Revenue (annual)
- ₹811.3 Cr
- Net profit (annual)
- ₹20.55 Cr
- P/E (TTM)
- 577.9×Sector 45.9×
- Promoter holding
- 74.45%+4.61% QoQ
- FII holding
- 0.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Orchid Pharma Ltd
All →Orchid Pharma Partnership
Orchid Pharma entered a licensing and supply agreement with Laboratorio Libra for Exblifep across nine Latin American markets. The partnership is expected to represent a potential opportunity of about USD 80 million over 10 years.
Orchid Pharma Fund Raise of ₹600 Cr
Orchid Pharma's board approved an enabling resolution to raise funds of up to ₹600 Crore through equity or debt securities via various permissible modes.
- Value
- ₹600.0 Cr
Orchid Pharma Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Orchid Pharma Board Meeting Date
Orchid Pharma has scheduled a board meeting for October 20, 2026, to consider options for raising funds. The company will explore various suitable funding avenues.
Orchid Pharma Other Announcement
Orchid Pharma Ltd has filed its quarterly Shareholding Pattern, providing a routine update on promoter and public shareholding as mandated by SEBI regulations.
Orchid Pharma Annual General Meeting
Orchid Pharma held its 33rd Annual General Meeting on September 29, 2026, where shareholders considered and approved routine business resolutions and related party transactions.
Other merger & restructuring announcements
All →Power Grid Corporation of India Merger & Restructuring Worth ₹73.46 Cr
Power Grid's board approved selling its entire stake in wholly owned subsidiary CTUIL to Grid Controller of India. The initial consideration is Rs 73.46 Crore, plus a later true-up amount.
- Value
- ₹73.46 Cr
Usha Martin Merger & Restructuring Worth ₹77 Cr
Usha Martin completed the Rs. 77 Crore slump sale of U M Cables' optical fibre business to R R Kabel. Transfer took effect 31 October 2026.
- Value
- ₹77.00 Cr
Usha Martin Merger & Restructuring
Usha Martin reports completion of its subsidiary U M Cables' business slump sale to R R Kabel, effective 31 October 2026. No consideration amount is disclosed.
KS Smart Technologies Merger & Restructuring Worth ₹0.01 Cr
KS Smart Technologies reported completion of a foreign subsidiary's incorporation, KS Smart Global Inc. in USA, on 22 October 2026. Transaction amount is ₹0.01 Crore.
- Value
- ₹0.01 Cr
KS Smart Technologies Merger & Restructuring
KS Smart Technologies reported that its step-down subsidiary KS Smart Global Inc. was incorporated in Delaware, USA, on October 22, 2026. The initial share subscription is stated as up to USD 510, held 51% by KSSPL.
AXISCADES Technologies Merger & Restructuring
AXISCADES Technologies disclosed that its step-down subsidiary Ulosia Holding AG incorporated AKKODIS AXISCADES AEROSPACE CANADA INC. in Canada. No cash was invested by the listed entity, and no value is stated.